Accelerate Time To Market With A Proven Team

Tap into our extensive network of 4,000+ GI sites, leverage exclusive data from 150+ central imaging projects, and benefit from our team of medical and operational experts for swift study startup and accelerated patient recruitment.

Site Network

We excel in expediting GI studies ahead of our competitors. through quicker study initiation and patient enrollment, surpassing the industry standard.

Innovation

Our commitment to cutting-edge technology and methodologies is key to our site network depth, retention, and enrolment success.

Results-driven

We deliver actionable insights, reducing time to market for our clients.

Therapeutic Focus

Driving health breakthroughs with a specialized focus on gastrointestinal therapeutics, Alimentiv stands at the forefront of innovation. We are dedicated to advancing research, accelerating clinical trials, and delivering actionable insights to redefine the future of GI healthcare.

Services

Pioneering advancements in gastrointestinal therapeutics, Alimentiv leads with innovation. Regardless of the stage or complexity of your project, our team can assist by providing streamlined clinical development solutions for your projects. From protocol design to recruitment, our experts can effectively address regulatory requirements, patient and site recruitment challenges, protocol designs and procedures, and patient-reported outcomes. Furthermore, our tailored problem-solving approach can assist you in managing costs and mitigating risks inherent to your clinical projects.


Latest Updates

News Jan 8, 2024
Alimentiv Announces Pierre Gaudreault as New Chief Executive Officer

London, Ontario, Canada, January 8, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce the appointment of Pierre Gaudreault as its Chief Executive Officer, effective...

News Nov 8, 2023
Alimentiv, AcelaBio, and PharmaNest Unite To Revolutionize Precision Medicine and AI Digital Pathology For NASH/MASH Clinical Trials.

LONDON, ON, November 8, 2023 – Alimentiv Inc., AcelaBio Inc., and PharmaNest Inc. are pleased to announce their collaborative effort aimed at revolutionizing precision medicine...

News Oct 13, 2023
Alimentiv Inc. Announces New Scientific Advisors Leading Research In GI-Related Therapeutics

London, Ontario, Canada, October 13, 2023, Alimentiv Inc. (“Alimentiv”), a leading Contract Research Organization focused on GI-related therapeutics, is pleased to announce the addition of...

Speak to a member
of our expert team

Contact us